Skip to content
InstaBriefs
Story timeline
1 updates

Merger Talks Report

AstraZeneca shares dropped 7% after reports revealed discussions over a potential $400 billion merger with Bristol Myers Squibb. The Financial Times reported that talks between the pharmaceutical giants have spanned several months.

updates

  1. AstraZeneca Shares Fall 7% Following $400B Merger Report

    AstraZeneca shares dropped 7% after reports revealed discussions over a potential $400 billion merger with Bristol Myers Squibb. The Financial Times reported that talks between the pharmaceutical giants have spanned several months.